Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin detemir in pre-diabetes associated with cystic fibrosis
2005-002997-31Phase 4Completed
- Sponsor
- Sheffield Children's Hospital
- Start
- Nov 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of insulin detemir in cystic fibrosis-related diabetes (CFRD), prediabetes and cystic fibrosis (CF) (2 arms), sponsored by Sheffield Children's Hospital. Primary endpoints: Change in FEV1, Change in FVC and 1 more. Started Nov 2005; status: completed.
02
Drugs
insulin detemir
03
Conditions
cystic fibrosis-related diabetes (CFRD)prediabetescystic fibrosis (CF)
Beyond the preview
Go deeper on 2005-002997-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002997-31.